Psychopharmacology
Overview
Psychopharmacology is a peer-reviewed journal that focuses on the study of the effects of drugs on the brain and behavior. It covers a wide range of topics including the mechanisms of drug action, clinical trials, and the development of new therapeutic approaches. With a multidisciplinary approach, this journal provides valuable insights into the field of psychopharmacology and its implications for mental health and neurological disorders.
Details
Details
Abbr.
Psychopharmacology (Berl)
Start
1976
End
Continuing
Frequency
Twenty four no. a year
p-ISSN
0033-3158
e-ISSN
1432-2072
Country
Germany
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 587
214
SJR / Ranks: 3468
1053
CiteScore / Ranks: 2600
7.40
JIF / Ranks: 2884
3.4
Recent Articles
1.
Smith A, Hamilton S, Murphy S, Cowen P, Harmer C
Psychopharmacology (Berl)
. 2025 Mar;
PMID: 40087174
Rationale: The 5-HT receptor is expressed widely across the brain and is implicated in the mechanism of action of several therapeutics for mood disorders. However, there is limited and contradictory...
2.
Delleli S, Ouergui I, Messaoudi H, Cazan F, Ballmann C, Ardigo L, et al.
Psychopharmacology (Berl)
. 2025 Mar;
PMID: 40064697
Rationale: How caffeine (CAF) intake and warm-up music combination affect male taekwondo athletes' performance during simulated combat is yet unstudied. Objective: This study examined the potential synergistic effects of low...
3.
Turton S, Hawkins P, Muller-Pollard C, Zois E, Conrod P, Zelaya F, et al.
Psychopharmacology (Berl)
. 2025 Mar;
PMID: 40053107
Rationale: It is hypothesised that modulation of striatal dopaminergic signalling plays a key role in the rewarding effects of opioids. The monetary incentive delay (MID) task is a functional magnetic...
4.
Salinsky L, Merritt C, Garcia E, Fox R, Zamora J, Anastasio N, et al.
Psychopharmacology (Berl)
. 2025 Mar;
PMID: 40035828
Rationale And Objectives: Overdose fatalities involving cocaine continue to rise with over 5.3 million cocaine users reported in the United States in 2022. The abuse liability of cocaine is reliant...
5.
Meredith L, Baskerville W, Lee C, Grodin E, Wassum K, Ray L
Psychopharmacology (Berl)
. 2025 Mar;
PMID: 40032780
No abstract available.
6.
LeCocq M, Najafipashaki S, Casale D, Laplante I, Samaha A
Psychopharmacology (Berl)
. 2025 Feb;
PMID: 39994055
Rationale: Environmental cues guide animals towards resources vital for survival but can also drive maladaptive reward-seeking behaviours, as in gambling and eating disorders. While conditioned stimuli (CSs) are paired with...
7.
Jha N, Ayoub S, Flesher M, Morton K, Sikkink M, de Guglielmo G, et al.
Psychopharmacology (Berl)
. 2025 Feb;
PMID: 39994054
Rationale: Despite improved life expectancy of people with HIV (PWH), HIV-associated neurocognitive impairment (NCI) persists, alongside deficits in sensorimotor gating and neuroinflammation. PWH exhibit high smoking rates, possibly due to...
8.
Rakowski E, King C, Thompson B, Santos G, Holmes E, Solberg Woods L, et al.
Psychopharmacology (Berl)
. 2025 Feb;
242(4):867-883.
PMID: 39979648
Rationale: Opioid misuse is a prominent public health concern, although patterns of use may confer different vulnerability to relapse. Continuous-access (ContA) self-administration has traditionally been used in preclinical models to...
9.
Caprioli D, Golden S, Baunez C, Venniro M
Psychopharmacology (Berl)
. 2025 Feb;
PMID: 39969568
No abstract available.
10.
Parlantza M, Pitsikas N
Psychopharmacology (Berl)
. 2025 Feb;
242(4):793-801.
PMID: 39964469
Rationale: Anxiety is a chronic severe psychiatric disorder. In a series of studies, the implication of the gaseous molecule nitric oxide (NO) in anxiety has been evidenced. Further, the outcome...